Search Results 91-100 of 25238 for liver disease
Mayo Clinic researchers are exploring several new treatment options for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary ...
Research in Dr. Hirsova's Liver Disease Immunobiology Lab at Mayo Clinic is focused on nonalcoholic steatohepatitis (NASH).
Polycystic liver disease (PLD) is characterized by the formation of numerous cysts in the liver, and can lead to severe symptomatic hepatomegaly. It is common ...
Uncovering the genetic basis for liver disease. Dr. Wangensteen's lab uses cutting-edge molecular genetics tools and genomics analysis of patient genetic ...
... liver disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition (THRIVE-1) ... Participant eligibility includes age, gender, type and stage of disease, ...
Since type 2 diabetes and non-alcoholic fatty liver disease are associated with metabolism, understanding the mechanisms that drive these cellular cargo trucks ...
PSC is an inflammatory disease of the bile ducts that results in inflammation and subsequent fibrosis that can lead to cirrhosis of the liver, liver failure and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.